Debiopharm International
UEI: YN12U3HMB8W7
• CAGE: SCGE0
Overview
Awardee Type
Parent
Company Description
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.
Name
Debiopharm International
Website
Headquarters
Lausanne, VD
Switzerland
Switzerland
Most Recent Award
Dec. 11, 2024
Calculating
Federal contract and grant recipient
DEBIOPHARM INTERNATIONAL SA
(UEI YN12U3HMB8W7, CAGE SCGE0)
is headquartered in Lausanne VD.
The organization
was founded in July 1979 and
federally registered in
January 2017.
Federal Award Analysis
Debiopharm International federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
DEBIOPHARM INTERNATIONAL SA
UEI
YN12U3HMB8W7
CAGE Code
SCGE0
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Other
Purpose of Registration
Federal Assistance Awards
Date Founded
July 16, 1979
Initial Registration
Jan. 17, 2017
Last Registration
June 3, 2024
Registration Activation
June 3, 2024
Registration Expiration
May 31, 2025
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
For Profit Organization
Country of Incorporation
CHE
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
No
People
Vendor contacts at Debiopharm International
Subcontract Awards
Debiopharm International subcontract awards
Subgrant Awards
Debiopharm International subgrant awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Debiopharm International